New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-

Updated on: October 30,2023 22

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-

Updated on:October 30,2023 22

HDAC6 score found to predict the response of some cancers to ricolinostat

by Bob Yirka , Medical XpressHDAC6 score in BC. (a) The number of samples and dataset of origin used to evaluate the HDAC6 regulon. (b) Overlap of the original and updated HDAC6 regulons. P value was

Updated on: December 21,2023 7

HDAC6 score found to predict the response of some cancers to ricolinostat

by Bob Yirka , Medical XpressHDAC6 score in BC. (a) The number of samples and dataset of origin used to evaluate the HDAC6 regulon. (b) Overlap of the original and updated HDAC6 regulons. P value was

Updated on:December 21,2023 7

FDA advisors to weigh new gene therapy for sickle cell anemia

by Cara MurezPatients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a newgene thera

Updated on: January 04,2024 5

FDA advisors to weigh new gene therapy for sickle cell anemia

by Cara MurezPatients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a newgene thera

Updated on:January 04,2024 5

Change in breast density over time linked to cancer risk

by Tamara Bhandari,Washington University in St. LouisChange in Mammographic Density (MD) for the Case Breast in Case Patients and Control Participants Over Time. Credit:JAMA Oncology

Updated on: January 04,2024 9

Change in breast density over time linked to cancer risk

by Tamara Bhandari,Washington University in St. LouisChange in Mammographic Density (MD) for the Case Breast in Case Patients and Control Participants Over Time. Credit:JAMA Oncology

Updated on:January 04,2024 9

New study reveals how blood cancer cells escape the immune system's natural killer cells

byUniversity of HelsinkiGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.11.008The advent of T-cell therapies, where cells of the immune system are directed towa

Updated on: January 26,2024 18

New study reveals how blood cancer cells escape the immune system's natural killer cells

byUniversity of HelsinkiGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.11.008The advent of T-cell therapies, where cells of the immune system are directed towa

Updated on:January 26,2024 18

Study examines causes of death in US breast cancer survivors

byWileyCredit: CC0 Public DomainSurvival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related

Updated on: December 22,2023 17

Study examines causes of death in US breast cancer survivors

byWileyCredit: CC0 Public DomainSurvival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related

Updated on:December 22,2023 17

Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainWhile it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developin

Updated on: December 19,2023 10

Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainWhile it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developin

Updated on:December 19,2023 10

Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

The PD-1 inhibitor pembrolizumab (Keytruda) displayed activity with a manageable safety profile in patients with certain rare and ultra-raresarcoma histotypes, according to findings from the phase 2 A

Updated on: November 07,2023 6

Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

The PD-1 inhibitor pembrolizumab (Keytruda) displayed activity with a manageable safety profile in patients with certain rare and ultra-raresarcoma histotypes, according to findings from the phase 2 A

Updated on:November 07,2023 6

Anti-anxiety drug may improve brain cancer survival chances

Anti-anxiety drug may improve brain cancer survival chancesbyFlinders UniversityGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A new study shows that cerebrospinal fluid reduces c

Updated on: October 30,2023 8

Anti-anxiety drug may improve brain cancer survival chances

Anti-anxiety drug may improve brain cancer survival chancesbyFlinders UniversityGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A new study shows that cerebrospinal fluid reduces c

Updated on:October 30,2023 8

Scientists identify promising therapeutic target for incurable brain cancer

byVirginia Commonwealth UniversityCredit: Unsplash/CC0 Public DomainResearchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and co

Updated on: December 27,2023 10

Scientists identify promising therapeutic target for incurable brain cancer

byVirginia Commonwealth UniversityCredit: Unsplash/CC0 Public DomainResearchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and co

Updated on:December 27,2023 10

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

Updated on: December 27,2023 6

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

Updated on:December 27,2023 6

How does obesity cause cancer?

Overweight and obesity is the second biggest cause of cancer in the UK – causing more than 1 in 20 cancer cases.The risk is higher the more overweight you are and the longer you are overweight for.Kee

Updated on: December 19,2023 16

How does obesity cause cancer?

Overweight and obesity is the second biggest cause of cancer in the UK – causing more than 1 in 20 cancer cases.The risk is higher the more overweight you are and the longer you are overweight for.Kee

Updated on:December 19,2023 16